1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
Biotech stocks typically are considered one of Wall Street’s more aggressive sources of growth. These companies spend years and gobs of money to create breakthrough biological treatments and diagnostic...
Seth Klarman was prescient in recognizing that the genomics revolution would supercharge the biotech industry.
As the calendar turns to 2020, investors need to appraise the stock markets in a new light. 2019 came and went with three interest-rate cuts – not the hikes many suspected at the start of the year...
More Investing News »